Prevalence of chronic kidney disease in a Nigerian family practice population

South African Family Practice

Volumn 51, Issue 2, 2009, Pages 132-137

  Afolabi, Muhammed O ^a   Abioye Kuteyi, E A ^b   Arogundade, F A ^b   Bello, I S ^b  

^a Ladoke Akintola University Teaching Hospital   (Nigeria)

^b OBAFEMI AWOLOWO UNIVERSITY   (Nigeria)

Author keywords

Chronic kidney disease; Family practice; Nigeria; Population; Prevalence

Indexed keywords

ALBUMIN; ANALGESIC AGENT; CREATININE;

ADOLESCENT; ADULT; AGE; AGED; ALBUMIN BLOOD LEVEL; ANALGESIC AGENT ABUSE; ARTICLE; BLOOD PRESSURE VARIABILITY; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; GENERAL PRACTICE; GLOMERULUS FILTRATION RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NIGERIA; PREVALENCE; QUESTIONNAIRE; RISK FACTOR; SCREENING TEST; URINALYSIS; WAIST HIP RATIO;

EID: 66949114272     PISSN: 20786190     EISSN: 20786204     Source Type: Journal    
DOI: 10.1080/20786204.2009.10873828     Document Type: Article

References (33)

1. AIHW. Chronic kidney disease in Australia, 2005. Australian Institute of Health and Welfare Cat. No. PHE 68. Canberra: AIHW. Available from http://www.aihw.gov.au (Accessed 27/10/2006).
2. WHO. The World Health Report 2003. Shaping the future. World Health Organization; 2003.
3. Beaglehole R, Yach D. Globalization and the prevention and control of non-communicable disease: the neglected chronic diseases of adults. Lancet 2003;362:903-8.
4. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kid Dis 2002;39(2 suppl):S1-226.
5. Johnson CA, Levey AS, Coresh J, Levin A, Lau J, Eknoyan G. Clinical practice guidelines for chronic kidney disease in adults. Part I: Definition, disease stages, evaluation, treatment and risk factors. Am Fam Physician 2004;70:869-76.
6. Akinsola A, Odesanmi WO, Oguniyi JO, Ladipo GOA. Diseases causing chronic renal failure in Nigerians - a prospective study of 100 cases. Afr J Med Sci 1989;18:131-7.
7. Abioye-Kuteyi EA, Akinsola A, Ezeoma IT. Renal disease: the need for community-based screening in rural Nigeria. Afr J Med Pract 1999;6(5):198-201.
8. Nwankwo EA, Nwankwo B, Mubi B. Prevalence of impaired kidney function in hospitalized hypertensive patients in Maiduguri, Nigeria. The Internet Journal of Internal Medicine 2006;6(1).
9. Kadiri S, Walker O, Salako BL, Akinkugbe O. Blood pressure, hypertension and correlates in urbanized workers in Ibadan, Nigeria: a revisit. J Hum Hypertens 1999;13:23-7.
10. Schena FP: Epidemiology of end-stage renal disease: international comparisons of renal replacement therapy. Kidney Int 2000;57:39-45.
11. Pugia MJ. Comparison of urine dipsticks with quantitative methods for microalbuminuria. Eur J Clin Chem Biochem 1997;35(9):693-700.
12. Agaba EI, Agaba PA, Wigwe CM. Use and abuse of analgesics in Nigeria: a community survey. Niger J Med 2004;13(4):379-82.
13. WHO. Obesity and overweight. Available from www.WHO/obesity/ overweight.htm (Accessed 23/05/2006).
14. SPSS for Windows. Release 11.0.0 SPSS Inc Standard Version; 2001.
15. McCellan WM, Knight DF, Karp H, Brown WW. Early detection and treatment of renal disease in hospitalized diabetic and hypertensive patients: important differences between practice and published guidelines. Am J Kidney Dis 1997;29:368-75.
16. Kissmeyer L, Kong C, Cohen J, Unwin RJ, Woolfson RJ, Neild GH. Community nephrology: audit of screening for renal insufficiency in a high risk population. Nephrol Dial Transplan 1999;14:2150-5.
17. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: third National Health and Nutrition Examination Survey. Am J Kidney Dis 2003;41:1-12.
18. Pusley D. Racial and ethnic disparities in renal disease. Kidney Int 2005;68:1364-5.
19. Norris KC, Agodoa LY. Unravelling the racial disparity associated with kidney disease. Kidney Int 2005;68:914-24.
20. Brenner BM, Mackenzie HS. Nephron mass as a risk factor for progression of renal disease. Kidney Int 1997;suppl 63:S124-7.
21. Nwankwo EA, Wudiri WW, Akinsola A. Risk factors for development of chronic kidney disease among Nigerians with essential hypertension. J Med Sci 2007;7(1).
22. Bosan IB. Chronic kidney disease in Nigeria: primary care physicians must intervene earlier. Nig Med Pract 2006;49(1/2):18-23.
23. Mulder WJ, Hillen HFP. Renal function and renal disease in the elderly. Eur J Int Med 2001;12:86-97.
24. Rowe JW, Andres R, Tobin JD, Norris AH, Shock NW. The effect of aging on creatinine clearance in men: a cross sectional and longitudinal study. J Ger 1996;31:155-63.
25. Chadban SJ, Briganti EM, Kerr PG, et al. Prevalence of kidney damage in Australian adults: the AusDiab kidney study. J Amer Soc Nephr 2003;14:S131-8.
26. Nwankwo EA, Ummate I. Environmental lead intoxication and chronic kidney disease: a review. Intern J Nephr 2006;3(1).
27. Alebiosu CO, Ayodele OE. Increasing prevalence of diabetes as a cause of end stage renal disease in Nigeria. Trop Doct 2004;35(1):35-8.
28. Alebiosu CO, Ayodele OE. The global burden of CKD and the way forward. Ethn Dis 2005;15:418-23.
29. Taylor EN, Stampfer MJ, Curhan GC. Obesity, weight gain, and the risk of kidney stones. J Amer Med Assoc 2005;293:455-62.
30. Stengel B, Tarver-Carr ME, Powe NR, Eberhardt MS, Brancati FL. Lifestyle factors, obesity and the risk of chronic kidney disease. Epid 2003;14:479-487.
31. Vupputuri S, Sandler DP. Lifestyle risk factors and chronic kidney disease. Ann Epid 2003;13(10):712-20.
32. Stengel B, Couchoud C, Cenee S, Hemon D. Age, blood pressure and smoking effects on chronic renal failure in primary glomerular nephropathies. Kid Int 2000;57:2519-26.
33. Hallan SI, Dahl K, Oien CM. Screening strategies for chronic kidney disease in the general population: follow-up of cross sectional health survey. BMJ 2006;333:1047.